About Errik Anderson
Form D filings for Mytide Therapeutics from 2022 to 2023 list Errik Anderson as director.
Errik Anderson first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Errik Anderson in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Errik Anderson works with at each company, as listed on that company's latest Form D.
Mytide Therapeutics, Inc. · Form D, Jan 6, 2023
JN
Jason Norris
Executive officer, director and promoter
DT
Dale Thomas
Executive officer, director and promoter